Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 23.60x is 60% above its 5-year average of 14.71x, near the low end of its 5-year range (5.96x–288.50x).
19.18% above its 12-month average of 19.80x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 5.96x.
INTEREST COVERAGE RATIO
23.60x
INTEREST COVERAGE RATIO AVG TTM
19.80x
INTEREST COVERAGE RATIO AVG 3Y
11.01x
INTEREST COVERAGE RATIO AVG 5Y
14.71x
INTEREST COVERAGE RATIO AVG 10Y
10.14x
INTEREST COVERAGE RATIO AVG 15Y
12.12x
INTEREST COVERAGE RATIO AVG 20Y
10.48x
CURRENT VS TTM AVG
+19.18%
CURRENT VS 3Y AVG
+114.25%
CURRENT VS 5Y AVG
+60.47%
CURRENT VS 10Y AVG
+132.84%
CURRENT VS 15Y AVG
+94.68%
CURRENT VS 20Y AVG
+125.15%
SECTOR MEDIAN · HEALTHCARE
6.88x
median of 82 covered companies
CURRENT VS SECTOR MEDIAN
+242.77%
vs the sector median at left
Abbott Laboratories
Market Cap
$177.12B
Interest Coverage Ratio
23.60x
TTM Avg
19.80x
3Y Avg
11.01x
5Y Avg
14.71x
Market Cap
$183.36B
Interest Coverage Ratio
11.43x
TTM Avg
6.56x
3Y Avg
7.26x
5Y Avg
7.18x
Market Cap
$185.26B
Interest Coverage Ratio
30.34x
TTM Avg
54.30x
3Y Avg
123.94x
5Y Avg
139.58x
Market Cap
$156.51B
Interest Coverage Ratio
5.78x
TTM Avg
5.55x
3Y Avg
10.96x
5Y Avg
11.04x
Market Cap
$203.12B
Interest Coverage Ratio
3.88x
TTM Avg
3.09x
3Y Avg
3.93x
5Y Avg
4.89x
Market Cap
$146.59B
Interest Coverage Ratio
19.38x
TTM Avg
19.02x
3Y Avg
23.18x
5Y Avg
23.65x
Market Cap
$135.05B
Interest Coverage Ratio
N/A
TTM Avg
55.58x
3Y Avg
55.58x
5Y Avg
55.58x
Market Cap
$130.27B
Interest Coverage Ratio
357.95x
TTM Avg
357.95x
3Y Avg
174.48x
5Y Avg
123.56x
Market Cap
$129.92B
Interest Coverage Ratio
7.26x
TTM Avg
6.11x
3Y Avg
6.76x
5Y Avg
6.22x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Abbott Laboratories (ABT) | $177.12B | 23.60x | 19.80x | 11.01x | 14.71x |
| Gilead Sciences, Inc. (GILD)vs › | $183.36B | 11.43x | 6.56x | 7.26x | 7.18x |
| Novo Nordisk A/S (NVO)vs › | $185.26B | 30.34x | 54.30x | 123.94x | 139.58x |
| Pfizer Inc. (PFE)vs › | $156.51B | 5.78x | 5.55x | 10.96x | 11.04x |
| Amgen Inc. (AMGN)vs › | $203.12B | 3.88x | 3.09x | 3.93x | 4.89x |
| Danaher Corporation (DHR)vs › | $146.59B | 19.38x | 19.02x | 23.18x | 23.65x |
| Intuitive Surgical, Inc. (ISRG)vs › | $135.05B | N/A | 55.58x | 55.58x | 55.58x |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.27B | 357.95x | 357.95x | 174.48x | 123.56x |
| Bristol-Myers Squibb Company (BMY)vs › | $129.92B | 7.26x | 6.11x | 6.76x | 6.22x |
| Medtronic plc (MDT)vs › | $118.53B | 9.04x | 8.61x | 8.24x | 8.04x |
Interest Coverage
23.6x
Debt/Equity
0.64
Current Ratio
1.38
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 5.96x |
| 2026-03-31 | 10.59x |
| 2025-12-31 | 18.76x |
| 2025-09-30 | 46.75x |
| 2025-06-30 | 16.96x |
| 2025-03-31 | 12.60x |
| 2024-12-31 | 13.09x |
| 2024-09-30 | 10.95x |
| 2024-06-30 | 10.04x |
| 2024-03-31 | 11.84x |
| 2023-12-31 | 7.93x |
| 2023-09-30 | 11.34x |
| 2023-06-30 | 9.88x |
| 2023-03-31 | 8.64x |
| 2022-12-31 | 8.79x |
| 2022-09-30 | 30.41x |
| 2022-06-30 | 27.45x |
| 2022-03-31 | 288.50x |
| 2021-12-31 | 27.49x |
| 2021-09-30 | 22.03x |
| 2021-06-30 | 14.69x |
| 2021-03-31 | 32.32x |
| 2020-12-31 | 21.18x |
| 2020-09-30 | 11.56x |
| 2020-06-30 | 3.99x |
| 2020-03-31 | 2.54x |
| 2019-12-31 | 10.18x |
| 2019-09-30 | 5.95x |
| 2019-06-30 | 4.51x |
| 2019-03-31 | 3.55x |
| 2018-12-31 | 4.39x |
| 2018-09-30 | 6.52x |
| 2018-06-30 | 5.29x |
| 2018-03-31 | 5.55x |
| 2017-12-31 | 3.52x |
| 2017-09-30 | 4.17x |
| 2017-06-30 | 1.70x |
| 2017-03-31 | -0.33x |
| 2016-09-30 | 13.70x |
| 2016-06-30 | 7.92x |
| 2016-03-31 | 9.03x |
| 2015-12-31 | 19.88x |
| 2015-09-30 | 17.39x |
| 2015-06-30 | 16.57x |
| 2015-03-31 | 16.49x |
| 2014-12-31 | 19.28x |
| 2014-09-30 | 20.89x |
| 2014-06-30 | 18.81x |
| 2014-03-31 | 10.14x |
| 2013-12-31 | 21.08x |
| 2013-09-30 | 12.78x |
| 2013-06-30 | 15.68x |
| 2013-03-31 | 15.00x |
| 2012-12-31 | 12.96x |
| 2012-09-30 | 2.04x |
| 2012-06-30 | 6.77x |
| 2012-03-31 | 6.20x |
| 2011-12-31 | 16.52x |
| 2011-09-30 | 4.79x |
| 2011-06-30 | 13.22x |
| 2011-03-31 | 8.94x |
| 2010-12-31 | 12.09x |
| 2010-09-30 | 7.92x |
| 2010-06-30 | 11.94x |
| 2010-03-31 | 12.44x |
| 2009-12-31 | 15.04x |
| 2009-09-30 | 12.18x |
| 2009-06-30 | 12.20x |
| 2009-03-31 | 8.54x |
| 2008-12-31 | 3.30x |
| 2008-09-30 | 11.17x |
| 2008-06-30 | 10.21x |
| 2008-03-31 | 8.05x |
| 2007-12-31 | 2.56x |
| 2007-09-30 | 6.32x |
| 2007-06-30 | 7.74x |
| 2007-03-31 | 6.43x |
| 2006-12-31 | -0.87x |
| 2006-09-30 | 0.01x |
| 2006-06-30 | 0.01x |
| 2006-03-31 | 30.83x |
| 2005-12-31 | 8.47x |
| 2005-09-30 | 20.58x |
| 2005-06-30 | 25.32x |
| 2005-03-31 | 26.87x |
| 2004-12-31 | 7.57x |
| 2004-09-30 | 27.86x |
| 2004-06-30 | 22.82x |
| 2004-03-31 | 26.88x |
| 2003-12-31 | 7.57x |
| 2003-09-30 | 22.66x |
| 2003-06-30 | 5.95x |
| 2003-03-31 | 26.29x |
| 2002-12-31 | 4.33x |
| 2002-09-30 | 0.02x |